Clinical Trial Update: Angiotensin II vs. Vasopressin in Septic Shock [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing Angiotensin II versus Vasopressin in septic shock has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Septic Shock

Drugs mentioned

• Angiotensin II (angiotensin II)
• VASOPRESSIN (VASOPRESSIN)

Snippet

Sponsor: University of New Mexico | Conditions: Septic Shock | Phase 4 | Status: WITHDRAWN